Our lab uses intravital imaging approaches to pinpoint critical events that drive tumour invasion and metastasis | @GarvanInstitute @KinghornCancer @UNSW
Sydney, Australia
Joined May 2019
- Tweets460
- Following462
- Followers996
- Likes1.2K
Invasion and Metastasis Lab retweeted
$ATX | #Amplia has enrolled and has begun dosing the first patient in the Company's new pancreatic cancer trial, exploring narmafotinib in combination with FOLFIRINOX in newly diagnosed advanced #pancreaticcancer patients. Read the ASX release: ampliatx.com/announcements/7…
Invasion and Metastasis Lab retweeted
Join us in our mission to save lives and transform the future of pancreatic cancer treatment. 💜
Click here to find out more: ow.ly/rjK750W6Jr0
#PancreaticCancer #PancreaticCancerAwareness #garvan #PurpleForAPurpose #FightPancreaticCancer #PurpleOurWorld
Invasion and Metastasis Lab retweeted
We’re excited to share news from the @ampliatx ACCENT trial: one patient with advanced pancreatic cancer showed no remaining cancer cells after treatment. This complete response is extremely rare in this aggressive cancer type.
$ATX UPDATE | #Amplia has today announced that a patient from ACCENT clinical trial in advanced #pancreatic cancer has now recorded a pathological complete response (pCR) - an extremely rare observation in this patient population. Read the #ASX release: bit.ly/ATX_pCR
Invasion and Metastasis Lab retweeted
$ATX | #Amplia has announced that a second patient enrolled in the ACCENT trial has recorded a confirmed complete response (CR). Read the ASX release: bit.ly/ATX_SecondCR #pancreaticcancer #clinicaltrial #cancertherapeutics #oncology #pharma #biotech #ASX
Invasion and Metastasis Lab retweeted
Did you catch this summary of the latest results from Amplia's ACCENT clinical trial in Small Caps this week? Take a look: bit.ly/ATX-SmallCaps-160625 $ATX #Amplia #pancreaticcancer #clinicaltrial #pharma #biotech #innovation
Invasion and Metastasis Lab retweeted
$ATX UPDATE | #Amplia has today announced that a patient from ACCENT clinical trial in advanced #pancreatic cancer has now recorded a pathological complete response (pCR) - an extremely rare observation in this patient population. Read the #ASX release: bit.ly/ATX_pCR
Invasion and Metastasis Lab retweeted
#Amplia has made headlines today following the announcement of a “pathological complete response” in an advanced #pancreaticcancer patient today. Biotech journalist Tim Boreham noted that Amplia shares had soared almost 50% following the news. Take a look: bit.ly/ATX-Stockhead_TimBore…
Invasion and Metastasis Lab retweeted
Integrins provide a bridge between cancer cells and the #ECM, playing a role in every stage of disease progression. 🌉
Drs. James Conway & Johanna Ivaska reveal the importance of integrin phosphorylation for cancer cell invasion. @NatureCellBio
🔗 go.nature.com/3Sm35ex
Invasion and Metastasis Lab retweeted
$ATX | #Amplia has today announced that trial initiation activities for the planned pancreatic cancer trial in the US have begun. Read the ASX release: bit.ly/ATX-US-Trial
#pancreaticcancer #clinicaltrial #drugdiscovery #innovation #cancertreatment
Invasion and Metastasis Lab retweeted
📢 Hunter Meeting 2025 - Abstract submissions close on Friday 14th February 2025, 5pm AEST!
The Hunter Meeting promises a fabulous line-up of international and national speakers in 2025.
Submit your abstract and register to attend!
Link: huntermeeting.org.au/abstrac…
Invasion and Metastasis Lab retweeted
Today - on #WorldCancerDay - we're grateful to our research collaborators, whose expertise and dedication make our clinical trials possible. Equal gratitude goes to the trial participants, and their families, who share our hope of improving outcomes for patients. #ATX #Amplia
Invasion and Metastasis Lab retweeted
1/Delighted to announce the newest paper from our lab, “Homologous recombination promotes non-immunogenic mitotic cell death upon DNA damage”, is out today in @NatureCellBio, nature.com/articles/s41556-0….
Invasion and Metastasis Lab retweeted
Congratulations to Dr Brooke Pereira on receiving a Fulbright Future Scholarship. Her work in pancreatic cancer research Garvan will benefit from this international opportunity. #FulbrightScholar #CancerResearch
Invasion and Metastasis Lab retweeted
Congratulations to CCB’s @dr_phil_gregory, @QuentenSchwarz and @TMEM_Samuel, who have been awarded @NHMRC Ideas Grant funding for 2025. Well done!
brnw.ch/21wPsyJ
Five UniSA projects awarded $5mill in @NHMRC grants announced today are set to improve cancer treatment, & help people prioritise their time building health
Invasion and Metastasis Lab retweeted
I'm very pleased to share that I have received a NHMRC Ideas grant to explore targeting fibrosis in combination with chemotherapy to improve treatment efficacy in pancreatic cancer. Also a big thank you to the CI/AI team - cant wait to get started! @Timpson_Lab @GarvanInstitute
Invasion and Metastasis Lab retweeted
VIDEO | #Amplia CEO & MD Dr Chris Burns and COO Dr Rhiannon Jones discuss the significance of Amplia’s latest clinical data from the ACCENT trial, and what investors can expect from Amplia in 2025.
Take a look: youtu.be/as23w84i1cs $ATX #clinicaltrial #pancreaticcancer #pharma
Invasion and Metastasis Lab retweeted
A $3.75 million grant from the Institute is supporting an innovative ‘personalised medicine framework’ that is giving hope to people with pancreatic cancer. Learn more about its progress: brnw.ch/21wPnHP
Invasion and Metastasis Lab retweeted
This #WorldPancreaticCancerDay, @PanKind_APCF is funding two new projects at Garvan. Both projects aim to overcome one of the biggest challenges in treating pancreatic cancer: finding ways to help promising new treatments reach and fight cancer cells more effectively.
Invasion and Metastasis Lab retweeted
Dr David Herrmann from @GarvanInstitute received a 2023 NHMRC Ideas Grant for his research to test whether blocking a key enzyme involved in the formation of fibrosis around pancreatic tumours can enhance treatment delivery and improve patient survival rates #WPCD2024
Invasion and Metastasis Lab retweeted
Medical research is crucial in the fight against pancreatic cancer. Our Phase 2a ACCENT trial of narmafotinib is underway in Australia & Korea, seeking better outcomes for patients. Learn more: accenttrial.com/ $ATX #Amplia #worldpancreaticcancerday #pancreaticcancer
